PHLDA2 antikoerper, ipl antikoerper, phlda2 antikoerper, BRW1C antikoerper, BWR1C antikoerper, HLDA2 antikoerper, IPL antikoerper, TSSC3 antikoerper, Ipl antikoerper, Tssc3 antikoerper, zgc:110459 antikoerper, pleckstrin homology like domain family A member 2 antikoerper, Pleckstrin homology-like domain family A member 2 antikoerper, pleckstrin homology like domain, family A, member 2 antikoerper, pleckstrin homology-like domain, family A, member 2 antikoerper, pleckstrin homology-like domain, family A, member 2 L homeolog antikoerper, PHLDA2 antikoerper, phla2 antikoerper, Phlda2 antikoerper, phlda2.L antikoerper, phlda2 antikoerper
Hintergrund
This gene is located in a cluster of imprinted genes on chromosome 11p15.5, which is considered to be an important tumor suppressor gene region. Alterations in this region may be associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene has been shown to be imprinted, with preferential expression from the maternal allele in placenta and liver.,PHLDA2,BRW1C,BWR1C,HLDA2,IPL,TSSC3,Epigenetics & Nuclear Signaling,Cancer,Tumor suppressors,Cell Biology & Developmental Biology,Apoptosis,Cell Cycle,Cell cycle inhibitors,PHLDA2